Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia‐Relevant Deficits

No abstract is available for this paper.

• Publication year

  2013

• Venue

  CNS Neuroscience & Therapeutics

• Publication date

  2013-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/cns.12081PMID 23611295PMCID PMC3663928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)

  2013cited by this paper
• Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date

  2013cited by this paper
• Ketamine: Use in Anesthesia

  2013cited by this paper
• Modeling ketamine effects on synaptic plasticity during the mismatch negativity.

  2013cited by this paper
• Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions

  2013cited by this paper
• Differential expression of parvalbumin in neonatal phencyclidine‐treated rats and socially isolated rats

  2013cited by this paper
• Is the acute NMDA receptor hypofunction a valid model of schizophrenia?

  2012cited by this paper
• Septohippocampal GABAergic neurons mediate the altered behaviors induced by n‐methyl‐D‐aspartate receptor antagonists

  2012cited by this paper
• Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

  2012cited by this paper
• Augmented gamma band auditory steady-state responses: support for NMDA hypofunction in schizophrenia.

  2012cited by this paper
• Baseline gamma power during auditory steady-state stimulation in schizophrenia

  2012influential reference
• Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments

  2012cited by this paper
• Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia.

  2012cited by this paper
• Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

  2012influential reference
• State-dependent increase of cortical gamma activity during REM sleep after selective blockade of NR2B subunit containing NMDA receptors.

  2012cited by this paper
• Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation.

  2012cited by this paper
• NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.

  2012cited by this paper
• Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.

  2012influential reference
• Uncertainties in baseline risk estimates and confidence in treatment effects

  2012cited by this paper
• Glutamatergic modulation of auditory information processing in the human brain.

  2012cited by this paper
• Targeting the Glutamatergic System to Treat Major Depressive Disorder

  2012cited by this paper
• Control of sleep and wakefulness.

  2012cited by this paper
• Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks.

  2012cited by this paper
• Phencyclidine/schizophrenia: one view toward the past, the other to the future.

  2012cited by this paper
• Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing

  2011cited by this paper
• Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia

  2011influential reference
• A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

  2011influential reference
• Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.

  2011cited by this paper
• Ketamine Disrupts Theta Modulation of Gamma in a Computer Model of Hippocampus

  2011cited by this paper
• Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia.

  2011cited by this paper
• Exploring intermediate phenotypes with EEG: working memory dysfunction in schizophrenia.

  2011cited by this paper
• A critical role for NMDA receptors in parvalbumin interneurons for gamma induction and behavior

  2011cited by this paper
• Neuromagnetic oscillations and hemodynamic correlates of P50 suppression in schizophrenia.

  2011cited by this paper
• The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia.

  2011cited by this paper
• Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.

  2011influential reference
• Glutamate Receptor Subtypes Mediating Synaptic Activation of Prefrontal Cortex Neurons: Relevance for Schizophrenia

  2011cited by this paper
• Translating Glutamate: From Pathophysiology to Treatment

  2011cited by this paper
• Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity

  2011cited by this paper
• A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research.

  2011cited by this paper
• Frontal areas contribute to reduced global coordination of resting-state gamma activities in drug-naïve patients with schizophrenia.

  2011cited by this paper
• Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia

  2011cited by this paper
• NMDA Receptor Hypofunction Phase Couples Independent γ-Oscillations in the Rat Visual Cortex

  2011cited by this paper
• Neuronal dynamics underlying high- and low-frequency EEG oscillations contribute independently to the human BOLD signal.

  2011cited by this paper
• Multiple origins of the cortical gamma rhythm

  2011cited by this paper
• Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice

  2010cited by this paper
• Impaired hippocampal–prefrontal synchrony in a genetic mouse model of schizophrenia

  2010cited by this paper
• Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin

  2010cited by this paper
• Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.

  2010cited by this paper
• Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.

  2010cited by this paper
• NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory.

  2010influential reference
• Hippocampal Oscillations in the Rodent Model of Schizophrenia Induced by Amygdala GABA Receptor Blockade

  2010influential reference
• Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory.

  2010cited by this paper
• Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.

  2010cited by this paper
• Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode Schizophrenia

  2010cited by this paper
• ouse behavioral endophenotypes for schizophrenia

  2010cited by this paper
• Abnormal neural oscillations and synchrony in schizophrenia

  2010influential reference
• NMDA receptor hypofunction phase-couples independent gamma oscillations in the rat visual cortex. Authors:

  2010cited by this paper
• Neuropsychological correlates of auditory perceptual inference: a mismatch negativity (MMN) study.

  2010cited by this paper
• Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.

  2010cited by this paper
• Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

  2010cited by this paper
• GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

  2010influential reference
• High‐frequency gamma oscillations coexist with low‐frequency gamma oscillations in the rat visual cortex in vitro

  2010cited by this paper
• Ketamine Modulates Theta and Gamma Oscillations

  2010influential reference
• Diminished parietal cortex activity associated with poor motion direction discrimination performance in schizophrenia.

  2010cited by this paper
• Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

  2010influential reference
• Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

  2010cited by this paper
• NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness

  2009cited by this paper
• A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

  2009influential reference
• Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

  2009cited by this paper
• Evidence-Based Medicine and Electrophysiology in Schizophrenia

  2009cited by this paper
• Maintaining network activity in submerged hippocampal slices: importance of oxygen supply

  2009cited by this paper
• From drugs to deprivation: a Bayesian framework for understanding models of psychosis

  2009cited by this paper
• Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats.

  2009cited by this paper
• Synaptic NR2A- but not NR2B-Containing NMDA Receptors Increase with Blockade of Ionotropic Glutamate Receptors

  2009cited by this paper
• Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia

  2009cited by this paper
• Steady state responses: electrophysiological assessment of sensory function in schizophrenia.

  2009cited by this paper
• A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.

  2009cited by this paper
• Auditory Sensory Gating in the Neonatal Ventral Hippocampal Lesion Model of Schizophrenia

  2009cited by this paper
• Persistent Hyperdopaminergia Decreases the Peak Frequency of Hippocampal Theta Oscillations during Quiet Waking and REM Sleep

  2009cited by this paper
• Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.

  2009cited by this paper
• The acute effects of NMDA antagonism: from the rodent to the human brain.

  2009cited by this paper
• The mismatch negativity: A review of underlying mechanisms

  2009cited by this paper
• Calcium binding protein markers of GABA deficits in schizophrenia — post mortem studies and animal models

  2009cited by this paper
• Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia.

  2009cited by this paper
• 2009 Special Issue: Network mechanisms of gamma oscillations in the CA3 region of the hippocampus

  2009cited by this paper
• Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex.

  2009cited by this paper
• Hyperdopaminergia and NMDA Receptor Hypofunction Disrupt Neural Phase Signaling

  2009cited by this paper
• Low-frequency EEG oscillations associated with information processing in schizophrenia.

  2009cited by this paper
• N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.

  2009cited by this paper
• Sensory-evoked gamma oscillations in chronic schizophrenia.

  2008cited by this paper
• Visual Gamma Oscillations in Schizophrenia: Implications for Understanding Neural Circuitry Abnormalities

  2008cited by this paper
• Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.

  2008cited by this paper
• Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations

  2008cited by this paper
• N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.

  2008influential reference
• Neurophysiological biomarkers for drug development in schizophrenia

  2008cited by this paper
• Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.

  2008cited by this paper
• A neural coding scheme formed by the combined function of gamma and theta oscillations.

  2008cited by this paper
• Differential regulation of the NMDA receptor by acute and sub‐chronic phencyclidine administration in the developing rat

  2008cited by this paper
• NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex

  2008cited by this paper
• In vitro activation of the medial septum—Diagonal band complex generates atropine‐sensitive and atropine‐resistant hippocampal theta rhythm: An investigation using a complete septohippocampal preparation

  2008cited by this paper

• A causal role of the NMDA receptor in recurrent processing during perceptual inference: NMDA receptor antagonist memantine selectively improves EEG decoding of the Kanizsa illusion

  2025cites this paper
• A causal role of the NMDA receptor in recurrent processing during perceptual integration

  2025cites this paper
• Gamma oscillations and excitation/inhibition imbalance: parallel effects of N-methyl D-aspartate receptor antagonism and psychosis.

  2025cites this paper
• Optogenetic inhibition of the limbic corticothalamic circuit does not alter spontaneous oscillatory activity, auditory-evoked oscillations, and deviant detection

  2024cites this paper
• Novel rapid treatment options for adolescent depression.

  2024cites this paper
• Understanding the Role of Early Life Stress and Schizophrenia on Anxiety and Depressive Like Outcomes: An experimental study.

  2024cites this paper
• Effects of acute and chronic ketamine administration on spontaneous and evoked brain activity.

  2024cites this paper
• Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats

  2024cites this paper
• Neuropsychiatric consequences of COVID-19 related olfactory dysfunction: could non-olfactory cortical-bound inputs from damaged olfactory bulb also contribute to cognitive impairment?

  2023cites this paper
• The impact of early life stress and schizophrenia on motor and cognitive functioning: an experimental study

  2023cites this paper
• Dopamine D4 Receptor Agonist Drastically Increases Delta Activity in the Thalamic Nucleus Reuniens: Potential Role in Communication between Prefrontal Cortex and Hippocampus

  2023cites this paper
• Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia

  2023cites this paper
• The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.

  2023cites this paper
• Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat

  2022cites this paper
• Maternal immune activation-induced proBDNF-mediated neural information processing dysfunction at hippocampal CA3-CA1 synapses associated with memory deficits in offspring

  2022cites this paper
• The effect of Ketamine on delta-range coupling between prefrontal cortex and hippocampus supported by respiratory rhythmic input from the olfactory bulb.

  2022cites this paper
• Translational approaches to influence sleep and arousal

  2022cites this paper
• Synchronized Auditory Gamma Response to Frontal Transcranial Direct Current Stimulation (tDCS) and its Inter-Individual Variation in Healthy Humans

  2022cites this paper
• N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli

  2022cites this paper
• Differential Effect of Dopamine D4 Receptor Activation on Low-Frequency Oscillations in the Prefrontal Cortex and Hippocampus May Bias the Bidirectional Prefrontal–Hippocampal Coupling

  2022cites this paper
• Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System

  2021cites this paper
• N-methyl-d-aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks.

  2021cites this paper
• NMDARs Containing NR2B Subunit Do Not Contribute to the LTP Form of Hippocampal Plasticity: In Vivo Pharmacological Evidence in Rats

  2021cites this paper
• Complexity of Brain Dynamics as a Correlate of Consciousness in Anaesthetized Monkeys

  2021cites this paper
• Neurochemistry of Visual Attention

  2021cites this paper
• Comprehensive mapping of cytochrome c oxidase activity in the rat brain after sub-chronic ketamine administration.

  2020cites this paper
• Application of a flexible polymer microECoG array to map functional coherence in schizophrenia model

  2020cites this paper
• THE THALAMIC MIDLINE NUCLEUS REUNIENS: POTENTIAL RELEVANCE FOR SCHIZOPHRENIA AND EPILEPSY.

  2020cites this paper
• Effects of Ketamine Administration on Auditory Information Processing in the Neocortex of Nonhuman Primates

  2020cites this paper
• Brain NMDA Receptors in Schizophrenia and Depression

  2020cites this paper
• Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling

  2020cites this paper
• Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice.

  2020cites this paper
• The Effects of Anesthetics on the Cortex—Lessons From Event-Related Potentials

  2020cites this paper
• Long-term potentiation prevents ketamine-induced aberrant neurophysiological dynamics in the hippocampus-prefrontal cortex pathway in vivo

  2019cites this paper
• An Overview of Animal Models Related to Schizophrenia

  2019cites this paper
• (2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions

  2019cites this paper
• NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans

  2019cites this paper
• Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis.

  2019cites this paper
• Modeling the schizophrenias: subunit-specific NMDAR antagonism dissociates frontal δ and hippocampal θ modulation of ~140 Hz oscillations

  2018cites this paper
• A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets.

  2018cites this paper
• Cannabinoid–glutamate interactions and neural oscillations: implications for psychosis

  2018cites this paper
• Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model

  2018cites this paper
• Subunit-specific NMDAR antagonism dissociates schizophrenia subtype-relevant oscillopathies associated with frontal hypofunction and hippocampal hyperfunction

  2018cites this paper
• A comprehensive analysis of auditory event‐related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology

  2018cites this paper
• Effects of Subanesthetic Ketamine Administration on Visual and Auditory Event-Related Potentials (ERP) in Humans: A Systematic Review

  2018cites this paper
• Modeling the schizophrenias: subunit-specific NMDAR antagonism dissociates oscillatory signatures of frontal hypofunction and hippocampal hyperfunction

  2017cites this paper
• New targets for rapid antidepressant action.

  2017cites this paper
• Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.

  2017cites this paper
• Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

  2017cites this paper
• Distinct retrosplenial cortex cell populations and their spike dynamics during ketamine-induced unconscious state

  2017cites this paper
• Altered Cortical Ensembles in Mouse Models of Schizophrenia.

  2017influential citation
• Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus

  2017cites this paper
• Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801.

  2017cites this paper
• Amygdala activity associated with social choice in mice

  2017cites this paper
• Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.

  2016cites this paper
• Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism

  2016cites this paper
• Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

  2016cites this paper
• Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.

  2016cites this paper
• Neural circuit dysfunction in schizophrenia: Insights from animal models.

  2016cites this paper
• GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

  2016cites this paper
• Target Validation and Pharmacological Characterization of Novel NMDAR Modulators

  2016cites this paper
• Neuropharmacology of altered brain oscillations in schizophrenia.

  2016cites this paper
• Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis: Can a Receptor Occupancy Normalization Approach Reduce the Gap between Animal and Human Experiments?

  2016cites this paper
• Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.

  2016cites this paper
• State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.

  2016cites this paper
• GluN 2 D N-Methyl-D-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine : Implications for Schizophrenia s

  2016cites this paper
• Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy

  2016cites this paper
• NMDA Receptor Antagonist Ketamine Distorts Object Recognition by Reducing Feedback to Early Visual Cortex.

  2016cites this paper
• Role of mitochondrial uncoupling protein-2 (UCP2) in higher brain functions, neuronal plasticity and network oscillation

  2016cites this paper
• Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans

  2016influential citation
• Visual mismatch negativity (vMMN): A review and meta-analysis of studies in psychiatric and neurological disorders.

  2016cites this paper
• The N-Methyl D-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway

  2016cites this paper
• GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia

  2016cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors

  2015cites this paper
• Biological Markers in Psychiatry and Its Relation with Translational Approaches: Brief Historical Review

  2015cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• The effect of NMDA receptor antagonism on cortical gamma power and synchronization in vivo

  2015cites this paper
• Recent insights into the mode of action of memantine and ketamine.

  2015cites this paper
• Modulation of hippocampal neuronal network oscillations by α7 nACh receptors.

  2015cites this paper
• Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia.

  2015cites this paper
• Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings.

  2015cites this paper
• Phencyclidine Disrupts the Auditory Steady State Response in Rats

  2015influential citation
• Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans : Evidence from Resting-State MEG-Recordings

  2015cites this paper
• Brain rhythms connect impaired inhibition to altered cognition in schizophrenia.

  2015cites this paper
• GluN2D NMDAR subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine; implications for schizophrenia

  2015cites this paper
• Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism.

  2015cites this paper
• Investigating the Primate Prefrontal Cortex Correlates of Cognitive Deficits In the Ketamine Model of Schizophrenia

  2014cites this paper
• Ketamine‐An Update on Its Clinical Uses and Abuses

  2014cites this paper
• Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice

  2014cites this paper
• 5-HT3a Receptors Modulate Hippocampal Gamma Oscillations by Regulating Synchrony of Parvalbumin-Positive Interneurons.

  2014cites this paper
• Oscillations dans la bande de fréquence gamma dans des modèles de rongeurs pour la schizophrénie

  2014cites this paper
• Gamma frequency oscillations in rodent models for schizophrenia

  2014cites this paper
• Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia

  2014cites this paper
• NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception

  2013cites this paper
• Treatment of Status Epilepticus with Ketamine, Are we There yet?

  2013cites this paper
• Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia

  2013cites this paper